ProShares Ultra Nasdaq Biotechnology (BIB) Short Interest Ratio & Short Volume → Collapse of the Petrodollar (From Colonial Metals) (Ad) Free BIB Stock Alerts $54.47 -0.95 (-1.71%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media ProShares Ultra Nasdaq Biotechnology Short Interest DataCurrent Short Volume16,200 sharesPrevious Short Volume37,100 sharesChange Vs. Previous Month-56.33%Dollar Volume Sold Short$817,290.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares1,630,000 sharesPercentage of Shares Shorted0.99%Today's Trading Volume15,321 sharesAverage Trading Volume36,918 sharesToday's Volume Vs. Average42% Short Selling ProShares Ultra Nasdaq Biotechnology ? Sign up to receive the latest short interest report for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIB Short Interest Over TimeBIB Days to Cover Over TimeBIB Percentage of Float Shorted Over Time Ad Behind the Markets"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> ProShares Ultra Nasdaq Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202416,200 shares $817,290.00 -56.3%N/A0.5 $50.45 4/15/202437,100 shares $1.86 million +201.6%N/A0.9 $50.24 3/31/202412,300 shares $707,742.00 -77.9%N/A0.3 $57.54 3/15/202455,700 shares $3.12 million +98.2%N/A1.3 $56.04 2/29/202428,100 shares $1.62 million +53.6%N/A0.7 $57.80 2/15/202418,300 shares $1.06 million +2.2%N/A0.6 $58.07 1/31/202417,900 shares $1.02 million No ChangeN/A0.5 $57.11 BIB Short Interest - Frequently Asked Questions What is ProShares Ultra Nasdaq Biotechnology's current short interest? Short interest is the volume of ProShares Ultra Nasdaq Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 16,200 shares of BIB short. Learn More on ProShares Ultra Nasdaq Biotechnology's current short interest. Is ProShares Ultra Nasdaq Biotechnology's short interest increasing or decreasing? ProShares Ultra Nasdaq Biotechnology saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 16,200 shares, a decrease of 56.3% from the previous total of 37,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProShares Ultra Nasdaq Biotechnology's short interest compare to its competitors? Here is how the short interest of companies compare to ProShares Ultra Nasdaq Biotechnology: Principal Healthcare Innovators ETF (0.36%), Invesco Nasdaq Biotechnology ETF (1.30%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (8.82%), Invesco S&P SmallCap Health Care ETF (0.03%), VanEck Biotech ETF (0.08%), VanEck Pharmaceutical ETF (24.24%), and iShares Biotechnology ETF (16.44%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ProShares Ultra Nasdaq Biotechnology stock? Short selling BIB is an investing strategy that aims to generate trading profit from ProShares Ultra Nasdaq Biotechnology as its price is falling. BIB shares are trading down $0.95 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProShares Ultra Nasdaq Biotechnology? A short squeeze for ProShares Ultra Nasdaq Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIB, which in turn drives the price of the stock up even further. How often is ProShares Ultra Nasdaq Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BTEC Short Squeeze IBBQ Short Squeeze FTXH Short Squeeze JDOC Short Squeeze BIS Short Squeeze PSCH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIB) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsProtect Your Bank Account Before It’s Too LateWeiss Ratings